MT-RNR2 and glioblastoma: Although more studies are needed to fully understand the mechanisms involved in the protumoral action of HN, our findings suggest a protumoral role of HN in the pathogenesis of GBM, expanding the perspective for the development of therapeutic strategies aimed at inhibiting HN function in GBM, either by the inhibition of its expression or blockade of HN receptors.